The National Institutes of Health (NIH) have issued new guidelines with restrictions for scientists seeking federal grants to use tissue from aborted babies for research.
The NIH said in a July 26 notice that ethics advisory boards will be involved in the review of applications to use human fetal tissue (HFT) obtained from elective abortions, and will be composed of “scientists, bio-ethicists and others.”
The new NIH guidelines require grant applicants wishing to make use of the tissue from aborted babies to provide “a justification of the use of HFT, details regarding procurement and costs, and information about how the applicant/contract offeror will use HFT,” or their application will not be reviewed. This section of the grant application has a 12-page limit.
According to the NIH, future grant applicants must indicate why their research goals “cannot be accomplished using an alternative to HFT” and what methods they have used to determine that no alternatives can be used.
In addition, applicants must describe what they plan to do with the human fetal tissue and how they will dispose of it when research is complete. They must describe a planned written, voluntary, informed consent process for cell/tissue donation, or a description and documentation of the process if cells or tissue were already obtained.
Full story at Catholic News Agency.